title: Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality.
abstract: BACKGROUND
  Non-high-density lipoprotein cholesterol (non-HDL-C) contains all known and potential atherogenic lipid particles. Therefore, non-HDL-C level may be as good a potential predictor of risk for cardiovascular disease (CVD) as low-density lipoprotein cholesterol (LDL-C).
  
  
  OBJECTIVE
  To determine whether non-HDL-C level could be useful in predicting CVD mortality and to compare the predictive value of non-HDL-C and LDL-C levels.
  
  
  METHODS
  Data are from the Lipid Research Clinics Program Follow-up Study, a mortality study with baseline data gathered from 1972 through 1976, and mortality ascertained through 1995. A total of 2406 men and 2056 women aged 40 to 64 years at entry were observed for an average of 19 years, with CVD death as the main outcome measure.
  
  
  RESULTS
  A total of 234 CVD deaths in men and 113 CVD deaths in women occurred during follow-up. Levels of HDL-C and non-HDL-C at baseline were significant and strong predictors of CVD death in both sexes. In contrast, LDL-C level was a somewhat weaker predictor of CVD death in both. Differences of 0.78 mmol/L (30 mg/dL) in non-HDL-C and LDL-C levels corresponded to increases in CVD risk of 19% and 15%, respectively, in men. In women, differences of 0.78 mmol/L (30 mg/dL) in non-HDL-C and LDL-C levels corresponded to increases in CVD risk of 11% and 8%, respectively.
  
  
  CONCLUSIONS
  Non-HDL-C level is a somewhat better predictor of CVD mortality than LDL-C level. Screening for non-HDL-C level may be useful for CVD risk assessment.
authors.affiliation: Director, Ciccarone Heart Center, The Johns Hopkins University, 600 W Wolfe St, Carnegie 538, Baltimore, MD 21287, USA. rblument@jhmi.edu
authors.forename: Y
authors.initials: Y
authors.lastname: Cui
authors.forename: R S
authors.initials: RS
authors.lastname: Blumenthal
authors.forename: J A
authors.initials: JA
authors.lastname: Flaws
authors.forename: M K
authors.initials: MK
authors.lastname: Whiteman
authors.forename: P
authors.initials: P
authors.lastname: Langenberg
authors.forename: P S
authors.initials: PS
authors.lastname: Bachorik
authors.forename: T L
authors.initials: TL
authors.lastname: Bush
mesh_terms: D000328:Adult; D002318:Cardiovascular Diseases / Q000097:blood* / Q000401:mortality*; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D005260:Female; D006801:Humans; D008074:Lipoproteins / Q000097:blood*; D008079:Lipoproteins, VLDL / Q000097:blood; D008297:Male; D008403:Mass Screening; D008875:Middle Aged; D015999:Multivariate Analysis; D011237:Predictive Value of Tests; D018570:Risk Assessment; D012307:Risk Factors; D017678:Sex Distribution
chemical_list: D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D008074:Lipoproteins; D008079:Lipoproteins, VLDL